Skip to main content

Cost-efficient European adaptations of global health economic models

Experience with model adaptations in Austria, Belgium, France, Germany, Italy, Norway, Netherlands, Spain, Sweden, the UK

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC launched Knowledge Zone with brief overviews of the market access landscape for key European countries

Market access is a rapidly changing field and the landscape varies from country to country. 

To provide an additional, easy-to-access source of high-level information about key themes in the market access landscape for medical technologies and in-vitro diagnostic tests, MTRC launched Knowledge Zone on the website. 

Currently, Knowledge Zone includes information about the payment model, funding (post-reimbursement approval by payers), and role of HTA for five key European countries: England, France, Germany, Italy, and Spain. In the coming weeks, the Zone will expand to other European countries. 

Access Knowledge Zone here